Singapore’s Industrial Production Remains In Contraction

By Nicholas Mapa of ING Economics

Economic and Financial Analysis • May 26, 2024 at 3:15 AM EDT

Industrial production dipped more than expected as global demand remains soft.

Free illustrations of Recession

Image Source: Pixabay

Industrial production fell 1.6%

Singapore’s industrial production dipped 1.6% year-over-year, worse than market expectations for -0.5% YoY. Production, however, was up from the previous month, posting a 7.1% YoY increase. In terms of components, the production of biomedical and electronics contracted while all other subsectors managed to post growth. Electronics were down 1.1% due mainly to a 2.6% YoY decline in semiconductors. For biomedical items, pharmaceuticals fell almost 55% YoY, outweighing the 13.6% YoY increase for medical technology production.

Industrial production track NODX decline

Source: Singapore Economic Development Board

IP continues to track NODX

Industrial production continued to track the direction of non-oil domestic exports (NODX). NODX fell more than expected for the same month, posting a 9.3% YoY drop versus expectations for an 8.9% YoY decline. Soft global demand translates to weaker industrial production activity and this could be one factor that could weigh on growth momentum for the second quarter. With global trade still anaemic, it's hard to expect a strong rebound in industrial production in the near term.

More By This Author:

Czech Confidence Softens But Recovery Goes On
Hungary’s Labour Market Shows Signs Of Renewed Strength
Think Ahead: What If US Inflation Is Much Lower Than We Think?

Disclaimer:

This publication has been prepared by the Economic and Financial Analysis Division of ING Bank N.V. (“ING”) solely for information purposes without regard to any particular user's investment objectives, financial situation, or means. ING forms part of ING Group (being for this purpose ING Group NV and its subsidiary and affiliated companies). The information in the publication is not an investment recommendation and it is not investment, legal or tax advice or an offer or solicitation to purchase or sell any financial instrument. Reasonable care has been taken to ensure that this publication is not untrue or misleading when published, but ING does not represent that it is accurate or complete. ING does not accept any liability for any direct, indirect or consequential loss arising from any use of this publication. Unless otherwise stated, any views, forecasts, or estimates are solely those of the author(s), as of the date of the publication and are subject to change without notice.

The distribution of this publication may be restricted by law or regulation in different jurisdictions and persons into whose possession this publication comes should inform themselves about, and observe, such restrictions.

Copyright and database rights protection exists in this report and it may not be reproduced, distributed or published by any person for any purpose without the prior express consent of ING. All rights are reserved. ING Bank N.V. is authorised by the Dutch Central Bank and supervised by the European Central Bank (ECB), the Dutch Central Bank (DNB) and the Dutch Authority for the Financial Markets (AFM). ING Bank N.V. is incorporated in the Netherlands (Trade Register no. 33031431 Amsterdam). In the United Kingdom this information is approved and/or communicated by ING Bank N.V., London Branch. ING Bank N.V., London Branch is deemed authorised by the Prudential Regulation Authority and is subject to regulation by the Financial Conduct Authority and limited regulation by the Prudential Regulation Authority. The nature and extent of consumer protections may differ from those for firms based in the UK. Details of the Temporary Permissions Regime, which allows EEA-based firms to operate in the UK for a limited period while seeking full authorisation, are available on the Financial Conduct Authority’s website.. ING Bank N.V., London branch is registered in England (Registration number BR000341) at 8-10 Moorgate, London EC2 6DA. For US Investors: Any person wishing to discuss this report or effect transactions in any security discussed herein should contact ING Financial Markets LLC, which is a member of the NYSE, FINRA and SIPC and part of ING, and which has accepted responsibility for the distribution of this report in the United States under applicable requirements.

Comments

Back to all articles